Instantly access the top oncology research from asco meetings—including abstracts, videos, posters, and slides. Camillo porta discussed the updated outcomes from phase iii trials in bladder and kidney cancer.
The 2024 asco annual meeting program will feature over 200 sessions complementing dr. Phase iii trial evaluates neoadjuvant immunotherapy for stage iii melanoma.
Join More Than 40,000 Oncology.
Blank et al, neoadjuvant nivolumab and ipilimumab in resectable stage iii melanoma, new england journal of medicine (2024).
The Theme Of This Year’s Conference Is The Art And Science Of Cancer Care:.
Users can view the full proceedings, or download individual tracks using the links below.
Images References :
Use The Online Program Guide To Plan.
Phase iii randomized clinical trial comparing the efficacy of neoadjuvant chemotherapy and standard treatment in patients with locally advanced colon cancer:
Phase Iii Trial Evaluates Neoadjuvant Immunotherapy For Stage Iii Melanoma.